A 6-hemolytic s t r e p t o c o c c a l p h a r y n g i t i s matched w i t h r e s p e c t t o a g e , s e x , r a c e , socioeconomic s t a t u s , d u r a t i o n of symptoms p r i o r t o t r e a t m e n t , and W B C a t o n s e t of t r e a t m e n t were randomized i n t o 10 B.I.D. o r Q.I.D. Cephalexin t r e a t m e n t regimens (B.I.D. = 10-15 mg/kg/dose, Q.I.D. = 5-8 mg/kg/dose). Compliance was a s s u r e d by followup phone c a l l s and i n s p e c t i o n of medication c o n t a i n e r s a t followup v i s i t s . E x c e l l e n t c l i n i c a l r e s p o n s e s and b a c t e r i o l o g i c c u r e ( n e g a t i v e c u l t u r e a t day 14 and 28) o c c u r r e d i n 31/33 B.1.D p a t i e n t s and 33/33 Q . I . D . p a t i e n t s . One c l i n i c a l and b a c t e r i ol o g i c f a i l u r e , and one b a c t e r i o l o g i c " r e l a p s e " ( p o s i t i v e c u l t u r e on day 28) o c c u r r e d i n t h e B.I.D. t r e a t m e n t group.
eference. P h y s i c i a n preference p t s d i d n o t a l t e r t h e r e s u l t s . A minimum o f f i v e days o f I V therapy was r e q u i r e d f o r i n c l u s i o n . b u t 60% o f t h e p t s r e c e i v e d >10 days o f therapy. The p t s were monitored w i t h s e r i a l CBC's, p l a t e l e t counts, u r i n a l y s i s , BUN, c r e a t i n i n e , SGOT, SGPT, and b i l i r u b i n . Occurrence o f secondary f e v e r s , rashes, and t h r o m b o p h l e b i t i s (TH) were t a b u l a t e d .
Treatment courses were successful i n 97.5%, b u t 4 p t s d i e d a f t e r b a c t e r i o l o g i c s t e r i l i z a t i o n . TH occurred i n 17/52 N p t s and 4/62 0 p t s . I n p t s over 10 years o f age r e c e i v i n g N 14/25 developed TH. Of e i g h t p t s switched b l i n d l y from N t o 0 because o f TH, a l l t o l e r a t e d t h e second drug. Three p a t i e n t s i n eact group developed severe neutropenia (WBCs500). Seven N and 5 0 p t s had drug f e v e r s . Elevated SGPT's occurred i n 13/62 0 and 6/52 N p t s . No r e n a l s i d e e f f e c t s were noted. Pharmacokinetic s t u d i e s were done on 12 p t s o f which s i x p t s had cross-over s t u d i e s on b o t h drugs. The h a l f -l i f e i n p r ematures was d i f f e r e n t than t h e o l d e r c h i l d (3.0 + 0.9 versus 0.6 c 0.1 h r s . ) There was no d i f f e r e n c e between 0 o r N h a l fl i v e s . Volumes o f d i s t r i b u t i o n , and t o t a l body clearances were From t h e p r i v a t e p r a c t i c e s of Lansing community p e d i a t r i c i a n s two groups of 33 p e d i a t r i c ambulatory p a t i e n t s with Group A 6-hemolytic s t r e p t o c o c c a l p h a r y n g i t i s matched w i t h r e s p e c t t o a g e , s e x , r a c e , socioeconomic s t a t u s , d u r a t i o n of symptoms p r i o r t o t r e a t m e n t , and W B C a t o n s e t of t r e a t m e n t were randomized i n t o 10 B.I.D. o r Q.I.D. Cephalexin t r e a t m e n t regimens (B.I.D. = 10-15 mg/kg/dose, Q.I.D. = 5-8 mg/kg/dose). Compliance was a s s u r e d by followup phone c a l l s and i n s p e c t i o n of medication c o n t a i n e r s a t followup v i s i t s . E x c e l l e n t c l i n i c a l r e s p o n s e s and b a c t e r i o l o g i c c u r e ( n e g a t i v e c u l t u r e a t day 14 and 28) o c c u r r e d i n 31/33 B.1.D p a t i e n t s and 33/33 Q . I . D . p a t i e n t s . One c l i n i c a l and b a c t e r i ol o g i c f a i l u r e , and one b a c t e r i o l o g i c " r e l a p s e " ( p o s i t i v e c u l t u r e on day 28) o c c u r r e d i n t h e B.I.D. t r e a t m e n t group.
No s i g n i f ic a n t t o x i c i t y o c c u r r e d i n any of t h e s t u d y p a t i e n t s . These f i n di n g s s u g g e s t t h a t (1) a B.I.D. Cephalexin regimen i s comparable t o a Q. 1 . 0 . regimen i n t h e t r e a t m e n t of Group A 8-hemolytic s t r e p t o c o c c a l p h a r y n g i t i s , ( 2 ) f u r t h e r e v a l u a t i o n s of B.I.D. C e f a l e x i n regimens l n ambulatory p a t i e n t s a r e w a r r a n t e d , and ( 3 ) c o n t r o l l e d c l i n i c a l t r i a l s can be p r a c t i c a l , p r o d u c t i v e and c o s t e f f e c t i v e u t i l i z i n g t h e p r i v a t e p h y s i c i a n s ' p r a c t i c e s a s a s o u r c of p a t i e n t p o p u l a t i o n s .
ROTECTION OF NEWBORN RATS FROM K1 E.
INFECTION. b e r t B o r t o l u s s i and P a t r i c i a F e r r i e r i , U n i v e r s i t y of i n n e s o t a Med. School, Dept. P e d i a t r . , Minneapolis. W e have shown p r e v i o u s l y t h a t newborn r a t s develop sepsis/men i n g i t i s a f t e r i . p . i n j e c t i o n of K1 E. c o l i . The p r e s e n t s t u d i e s examine t h e e f f e c t of p a s s i v e immunization on i n f e c t i o n . Preqnan r a t s were immunized X2 by i . v . i n j e c t i o n o f f o r m a l i n -k i l l e d E.
c o l i ( t y p e 07:Kl:H?). Some members of subsequent l i t t e r s were ex changed s h o r t l y a f t e r b i r t h w i t h pups from saline-immunized moth e r s . A t age 5 d a y s , a l l pups were c h a l l e n g e d by i . p . i n j e c t i o n o 1 . 2 x lo1 CFU of a K 1 E. c o l i s t r a i n (018ac:Kl:H7). Q u a n t i t a t i v e blood c u l t u r e s were o b t a i n e d d a i l y . Of 29 pups born t o and n u r s e by K1-immunized dams, 34% and 41% had b a c t e r e m i a 1 and 3 days l a t e r v s . 59% o f 29 unexchanged pups from saline-immunized dams ( p >0.05). M o r t a l i t y r a t e s were 38% (Kl) and 34% ) which r e a c t s w i t h K 1 a n t i g e n (Group I ) ; normal h . s . (Group 1 1 ) ; o r w a t e r (Group 111) f o r 2-4 days and c h a l l e n g e d a t 5 days of age. Three days l a t e r 54% o f Group I had bacteremia v s . 60% of Groups I1 and 111; however, m o r t a l i t y r a t e s were 8 % , 33% and 30%, r e s p e ct i v e l y ( p <0.05). Group I had i n i t i a l b a c t e r e m i a w i t h geometric mean CFU/ml 1 l o g lower t h a n t h a t o f Groups I1 and 111.
T h i s method o f m a t e r n a l immunization a g a i n s t K1 E. c o l i gave poor p r o t e c t i o n t o r a t pups. O r a l f e e d s of a n t i -c a p s u l a r a n t ibody f a v o r a b l y modified i n t e n s i t y of b a c t e r e m i a and m o r t a l i t y .
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WSE AND EFFICACY OF ARA-A I N NEONATAL HERPESVIRUS 755 1INFECTIONS. Yvonne J. Bryson, James .. connor, and
Lawrence Sweetman. Departments of P e d i a t r i c s , Univers i t y of C a l i f o r n i a , Los Angeles and San Diego Schools of Medicine Ara-A h a s proven e f f i c a c y i n Herpesvirus (HSV) e n c e p h a l i t i s and i n V a r i c e l l a Z o s t e r (VZ) i n f e c t i o n s i n immunosuppressed pat i e n t s . Using l i q u i d chromatography (HPLC) and a n o v e l b i o a s s a y method t o d e t e c t a r a -n u c l e o s i d e s and a n t i v i r a l a c t i v i t y (AVA) ,
we have observed a s i g n i f i c a n t d i f f e r e n c e i n dose r e s p o n s e s between i n f a n t s and a d u l t s . A t 10 mg/kg/12 hour d o s e s , i n f a n t p l a sma by HPLC c o n t a i n e d an average of 4.5 pg/ml ara-Hx and i n 4 o u t of 5 samples < . 0 2 vg/ml of ara-A. At 20 mg/kg/12 hour d o s e s , a r aHx r o s e t o average 5.6 pg/ml w i t h 3 o f 4 ara-A v a l u e s c.01 ug/ml.
A t 20 mg/kg/6 hour i n f u s i o n , ara-Hx averaged 8 . 1 pg/ml and a l l plasma samples c o n t a i n e d ara-A a v e r a g i n g 0.084 pg/ml. I n 2 neon a t e s . HSV 2 d i s e a s e p r o g r e s s e d u n t i l ara-A reached >15 mg/kg/l2 hour d o s e s . At 35 mg/kg/12 h o u r s , n e o n a t a l plasmas c o n t a i n e d mear ara-A l e v e l s of .224 ug/ml w i t h CSF l e v e l s of .064 ug/ml when measured by b i o a s s a y ( s e n s i t i v i t y .004 -.008 ug/ml). These compared f a v o r a b l y with mean ara-A plasma l e v e l s achieved i n a d u l t s which were .023 pg/ml and .119 ug/ml a t d o s e s of 1 0 and 15 mg/kg/ 12 hour i n f u s i o n r e s p e c t i v e l y , w i t h .081 vg/ml i n CSF. These f i n d i n g s i n d i c a t e t h a t blood l e v e l s c o r r e l a t e d d i r e c t l y w i t h t h e amount of d r u g i n f u s e d and i n v e r s e l y w i t h t h e d u r a t i o n of i n f us i o n , and a l s o s u g g e s t t h a t h i g h e r ara-A d o s e s w i t h p o t e n t i a l t o x i c i t y w i l l be r e q u i r e d f o r s u c c e s s f u l t r e a t m e n t of t h e more r e s i s t a n t HSV 2 s t r a i n s i n neonates. The h i g h m o r t a l i t y i n neonatal Group B Beta Hemolytic S t r e p t ococcal (BHS-Gr B) septicemia may be r e l a t e d t o d i f f i c u l t y i n t h e e a r l y r e c o g n i t i o n o f s e p t i c shock (SS). The o b j e c t i v e o f t h i s st^ dy was t o d e s c r i b e SS i n 6 i n f a n t s who developed BHS-Gr B sepsis a t o r s h o r t l y a f t e r b i r t h . The i n f a n t s (B.W.=940-2750, B.A.=27-37 wks) were s t u d i e d from b i r t h u n t i l recovery i n one and death i n t h e remaining 5. Heart r a t e , a r t e r i a l blood pressure (ABP), c e n t r a l venous pressure (CVP), r e c t a l -s k i n temperatures, and a rt e r i a l blood gases were s e r i a l l y measured. During t h e f i r s t 10 hours, hypotension w i t h wide p u l s e pressure and low d i a s t o l i c pressure was c o n s i s t a n t l y present. Color, s k i n p e r f u s i o n , CVP ard r e c t a l -s k i n temperatures were normal. M i l d metabolic acidosiswaz t h e o n l y a b n o r m a l i t y i n t h e blood gases. I n t h e 5 i n f a n t s who died, CVP increased t o abnormal l e v e l s . The d i a s t o l i c pressure increased and t h e s y s t o l i c pressure decreased f u r t h e r r e s u l t i n g i n a narrowing o f p u l s e pressure. Core temperature and m e t a b o l i c a c i d o s i s increased w h i l e t h e r e was a decrease i n p e r i p h e r a l perf u s i o n and a change i n t h e s k i n c o l o r t o grey. SS as a r e s u l t o f BHS-Gr B septicemia was c h a r a c t e r i z e d by an e a r l y phase w i t h pin1 hypotension and p e r i p h e r a l v a s o d i l a t i o n . I n t h e i n f a n t s who died. grey hypotension w i t h p e r i p h e r a l v a s o c o n s t r i c t i o n and h e a r t f a i l u r e supervened. We p o s t u l a t e t h a t r e c o g n i t i o n and therapy o f t h e e a r l y phase o f SS may prevent progression o f t h e disease and a Departments of Otolaryngology and P e d i a t r i c s , C h i l d r e n ' s H o s p i t a l of P i t t s b u r g h and U n i v e r s i t y of P i t t s b u r g h School of Medicine, P i t t s b u r g h , Pa.
MICROBIOLOGY OF RECURRENT AND CHRONIC OTITIS
A s t u d y was conducted of 274 c h i l d r e n who had r e c u r r e n t a c u t e o r c h r o n i c o t i t i s media w i t h e f f u s i o n o r both.
Fortyf i v e p e r c e n t of t h e e a r s with e f f u s i o n were found t o c o n t a i n b a c t e r i a and 11 p e r c e n t contained b a c t e r i a t h a t were "probable pathogens (S. pneumoniae, H. i n f l u e n z a e , and S. pyogenes). B a c t e r i a were a l s o found i n 40 p e r c e n t o t t h e e a r s without e f f u s i o n s . The type of organism found d i d not vary w i t h t h e age of t h e s t u d i e d o r t h e season of t h e y e a r . The s i g n i f i c a n c e o t t h e s e b a c t e r i a i n t h e e t i o l o g y of c h r o n i c o t i t i s media with e f f u s i o n remains t o be demonstrated.
